Y-mAbs Therapeutics (YMAB) PT Raised to $22 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts YMAB Hot Sheet
Price: $8.61 --0%
Rating Summary:
5 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 18
Rating Summary:
5 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 18
Join SI Premium – FREE
H.C. Wainwright analyst Robert Burns raised the price target on Y-mAbs Therapeutics (NASDAQ: YMAB) to $22.00 (from $21.00) while maintaining a Buy rating.
You May Also Be Interested In
- Yamazaki Baking (2212:JP) PT Lowered to JPY4,100 at UBS
- Chapters Group AG (CHG:GR) PT Raised to EUR50 at Berenberg
- Recticel SA (REC:BB) PT Raised to EUR15.50 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
